“Crash Global Effort Underway to Increase Coronavirus Testing”
“There’s (a) fine balance between getting the test out there fast and making sure the test is accurate,” says Dr. Tim Alcorn, Director of Medical Devices and Diagnostics at Latham …
Pamela Stegemerten
Latham BioPharm Group is thrilled to announce the addition of three new team members
LBG is thrilled to announce the addition of Dr. Robert Casillas, Dr. Thijs Beuming and Dr. Darrel J. Rezac to our Team—each of whom brings unique expertise that widens the …
Watch now! Roundtable Discussion: Cell and Gene Therapies — Keep the Work In-House, or Use a Third Party?
LBG’s Dr. Joseph Rininger, as an industry leader in Cell & Gene Therapies, was invited to participate in a roundtable discussion at BIO International 2019 on this topic. Questions posed to the panel by BioProcess Insider editor Dan …
Capacity Analysis for Viral Vector Manufacturing: Is There Enough?
LBG’s Dr. Joseph Rininger, Dr. Ashley Fennell, Dr. Lauren Schoukroun-Barnes, Christopher Peterson and Dr. Joshua Speidel recently published a joint article titled, Capacity Analysis for Viral Vector Manufacturing: Is There Enough?. The article discusses …